Aimee Shu, MD

1 location · Stanford Health Care · 3,152 clinicians in this group

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

16 plans · 2 carriers

Licence A121914 · Current

Licensed to practise in California · since 2012 · expires 2027-11-30 · Harvard Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

1 licence

• Texas N8242Physician License · since 2010 · expires 2024-11-30
  Canc Non-RenewalNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

• Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
  Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

$3,425

Medicare paid this office $3,425 for 29 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Who their Medicare patients are

29 Original Medicare patients in 2024. Average age 77 · Health risk score 1.13. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.

Conditions among them: High blood pressure 52%.

The office billed $14,097, Medicare allowed $5,493 and paid $3,425; for 30 services of 1 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

$94,040

Pharmacies billed $94,040 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 101) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.

61 generic and 26 brand-name prescriptions · $94,040 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Year by year

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

$76 in 2019

A payment is not proof that care is biased.

Medicare did not publish checkup rates for this clinician.

NPI

1720209612

Licence

CA A121914, TX N8242California A121914: Current · expires 2027-11-30Texas N8242: Canc Non-Renewal

Trained

Harvard Medical School, 2003

Group

Stanford Health Care

Video visits

Lists video visits

Gender

Female